自发性脑出血急性期治疗的进展(4)
[9] Koga M，Toyoda K，Naganuma M，et al.Nationwide survey of antihypertensive treatment for acute intracerebral hemorrhage in Japan[J].Hypertens Res，2009，32(9)：759-764.
[10] Powers W J，Zazulia A R，Videen T O，et al.Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage[J].Neurology，2001，57(1)：18-24.
[11] Koch S，Romano J G，Forteza A M，et al.Rapid blood pressure reduction in acute intracerebral hemorrhage：feasibility and safety[J].Neurocrit Care，2008，8(3)：316-321.
, 百拇医药
[12] Anderson C S，Huang Y，Wang J G，et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT)：a randomised pilot trial[J].Lancet Neurol，2008，7(5)：391-399.
[13] Qureshi A I，Bliwise D L，Bliwise NG， et al.Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage：a retrospective analysis with a random effects regression model[J].Crit Care Med，1999，27(3)：480-485.
[14] Kidwell C S，Saver J L，Mattiello J，et al.Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage[J].Neurology，2001，57(9)：1611-1617.
, 百拇医药
[15] Fernandes H M，Siddique S，Banister K，et al.Continuous monitoring of ICP and CPP following ICH and its relationship to clinical，radiological and surgical parameters[J].Acta Neurochir Suppl， 2000，76(21)：463-466.
[16] Anderson C S.Medical management of acute intracerebral hemorrhage[J].Curr Opin Crit Care，2009，15(2)：93-98.
[17] Steiner T，Diringer M N，Schneider D，et al.Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage：risk factors，clinical impact，and effect of hemostatic therapy with recombinant activated factor VII[J].Neurosurgery，2006，59(4)：767-773.
, 百拇医药
[18] Grillo P，Velly L，Bruder N.Intracerebral haemorrhage，what’s new[J].Ann Fr Anesth Reanim，2006，25(8)：868-873.
[19] Sutherland C S，Hill M D，Kaufmann A M，et al.Recombinant factor VIIa plus surgery for intracerebral hemorrhage[J].Can J Neurol Sci，2008，35(5)：567-572.
[20] Libman R B，Lungu C，Kwiatkowski T.Multiple ischemic strokes associated with use of recombinant activated factor VII[J].Arch Neurol，2007，64(6)：879-881.
[21] Mayer S A，Brun N C， Broderick J，et al.Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage[J].Stroke，2005，36(1)：74-79.
[22] Mayer S A，Brun N C，Begtrup K，et al.Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage[J].N Engl J Med，2008，358(20)：2127-2137., 百拇医药(张斌)
[10] Powers W J，Zazulia A R，Videen T O，et al.Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage[J].Neurology，2001，57(1)：18-24.
[11] Koch S，Romano J G，Forteza A M，et al.Rapid blood pressure reduction in acute intracerebral hemorrhage：feasibility and safety[J].Neurocrit Care，2008，8(3)：316-321.
, 百拇医药
[12] Anderson C S，Huang Y，Wang J G，et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT)：a randomised pilot trial[J].Lancet Neurol，2008，7(5)：391-399.
[13] Qureshi A I，Bliwise D L，Bliwise NG， et al.Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage：a retrospective analysis with a random effects regression model[J].Crit Care Med，1999，27(3)：480-485.
[14] Kidwell C S，Saver J L，Mattiello J，et al.Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage[J].Neurology，2001，57(9)：1611-1617.
, 百拇医药
[15] Fernandes H M，Siddique S，Banister K，et al.Continuous monitoring of ICP and CPP following ICH and its relationship to clinical，radiological and surgical parameters[J].Acta Neurochir Suppl， 2000，76(21)：463-466.
[16] Anderson C S.Medical management of acute intracerebral hemorrhage[J].Curr Opin Crit Care，2009，15(2)：93-98.
[17] Steiner T，Diringer M N，Schneider D，et al.Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage：risk factors，clinical impact，and effect of hemostatic therapy with recombinant activated factor VII[J].Neurosurgery，2006，59(4)：767-773.
, 百拇医药
[18] Grillo P，Velly L，Bruder N.Intracerebral haemorrhage，what’s new[J].Ann Fr Anesth Reanim，2006，25(8)：868-873.
[19] Sutherland C S，Hill M D，Kaufmann A M，et al.Recombinant factor VIIa plus surgery for intracerebral hemorrhage[J].Can J Neurol Sci，2008，35(5)：567-572.
[20] Libman R B，Lungu C，Kwiatkowski T.Multiple ischemic strokes associated with use of recombinant activated factor VII[J].Arch Neurol，2007，64(6)：879-881.
[21] Mayer S A，Brun N C， Broderick J，et al.Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage[J].Stroke，2005，36(1)：74-79.
[22] Mayer S A，Brun N C，Begtrup K，et al.Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage[J].N Engl J Med，2008，358(20)：2127-2137., 百拇医药(张斌)